Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease.
作者信息
van Hees P A
出版信息
Acta Gastroenterol Belg. 1987 Sep-Oct;50(5):555-9.
PMID:2902723
Abstract
摘要
相似文献
1
Sulfasalazine and new analogues in inflammatory bowel disease, with focus on Crohn's disease.
Acta Gastroenterol Belg. 1987 Sep-Oct;50(5):555-9.
2
Sulfasalazine and new analogues.
Am J Gastroenterol. 1986 Feb;81(2):141-4.
3
Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
Dan Med Bull. 1989 Sep;36(4):378-93.
4
[Exacerbation of ulcerative colitis and Crohn's disease following a change-over from salazosulfapyridine to 5-aminosalicylic acid].
Dtsch Med Wochenschr. 1986 May 2;111(18):721-2.
5
Drug insight: aminosalicylates for the treatment of IBD.
Nat Clin Pract Gastroenterol Hepatol. 2007 Mar;4(3):160-70. doi: 10.1038/ncpgasthep0696.
6
[Therapeutic efficacy of 5-ASA molecules in idiopathic intestinal inflammatory diseases: critical review].
Acta Gastroenterol Belg. 1992 Sep-Dec;55(5-6):462-71.
7
Will there be a next generation of sulfasalazine?
Gastroenterology. 1982 Nov;83(5):1138-41.
8
Which 5-ASA?
Gut. 2002 Oct;51(4):548-9. doi: 10.1136/gut.51.4.548.
9
Oral 5-aminosalicylic acid preparations in treatment of inflammatory bowel disease. An update.
Dig Dis Sci. 1987 Dec;32(12 Suppl):57S-63S. doi: 10.1007/BF01312465.
10
[New developments in the treatment of inflammatory bowel diseases. What is certain?].
Z Gastroenterol Verh. 1990 Apr;25:150-2.
引用本文的文献
1
Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents.
Saudi J Gastroenterol. 2025 May 1;31(3):107-136. doi: 10.4103/sjg.sjg_171_24. Epub 2024 Aug 30.
2
Antibiotic and Antiinflammatory Therapy Transiently Reduces Inflammation and Hypercoagulation in Acutely SIV-Infected Pigtailed Macaques.
PLoS Pathog. 2016 Jan 14;12(1):e1005384. doi: 10.1371/journal.ppat.1005384. eCollection 2016 Jan.
Zotero 插件